An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma

Stopped Study was closed early as the sponsor decided not to continue development of certain treatment combinations.

Conditions

• Gastric and Gastroesophageal Junction Carcinoma

Interventions

• DRUG: Atezolizumab
• DRUG: Capecitabine
• DRUG: Oxaliplatin
• DRUG: Tiragolumab

Sponsor

Hoffmann-La Roche